CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-28 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +38,500 | 38,500 | ||
| 2020-02-28 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Restricted Stock Units | +123,150 | 123,150 | ||
| 2020-02-28 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +246,250 | 246,250 | ||
| 2020-02-28 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Restricted Stock Units | +123,150 | 123,150 | ||
| 2020-02-28 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +246,250 | 246,250 | ||
| 2020-02-28 | Lurker Nancy President & CEO | Grant or award · Restricted Stock Units | +374,000 | 374,000 | ||
| 2020-02-28 | Lurker Nancy President & CEO | Grant or award · Stock Option (Right to Buy) | +748,000 | 748,000 | ||
| 2020-02-21 | Lurker Nancy President & CEO | Exercise or conversion | +137,174 | 476,800 | ||
| 2020-02-21 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −137,174 | 274,349 | ||
| 2019-11-15 | Elston George Chief Financial Officer | Purchase | +10,000 | $1.43 | $14K | 10,000 |
| 2019-11-14 | Elston George Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +745,000 | 745,000 | ||
| 2019-10-12 | Lurker Nancy President & CEO | Shares withheld for taxes | −10,745 | $2.11 | $23K | 314,455 |
| 2019-10-12 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,450 | $2.11 | $5K | 43,047 |
| 2019-10-09 | Mazzo David J Director | Exercise or conversion | +33,333 | $1.95 | $65K | 200,083 |
| 2019-10-09 | Mazzo David J Director | Exercise or conversion · Stock Option (Right to Buy) | −33,333 | 0 | ||
| 2019-09-06 | Mazzo David J Director | Exercise or conversion | +417 | 166,750 | ||
| 2019-09-06 | Mazzo David J Director | Exercise or conversion · Deferred Stock Unit | −417 | 0 | ||
| 2019-07-15 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2019-06-27 | Ross Leonard S | Exercise or conversion | +6,667 | 92,005 | ||
| 2019-06-27 | Ross Leonard S | Shares withheld for taxes | −1,961 | $1.65 | $3K | 90,044 |
Page 34 of 40 · 795 trades